CD36 and acute myeloid leukemia: LRP1, which is involved in receptor-mediated endocytosis and lipoprotein metabolism, increased in multiple cell types after metabolic changes similar to those that regulate CD36 and CD36L1 (Figure 1E and Figure S3A), including in vivo, in engrafted AML cells (Figure S3B).